Weekly shot aims to tame stubborn cholesterol
NCT ID NCT07477704
Summary
This study is testing if a cholesterol-lowering drug called alirocumab is safe and effective when given as a weekly injection instead of the usual schedule. It will involve 420 adults with high cholesterol. Researchers will measure how much the drug lowers 'bad' cholesterol and track any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.